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Introduction {#sec1}
============

In cancer biology, mitochondria are key organelles for understanding the behavior of cancer cells. Mitochondria are involved in fine-tuning cellular metabolism, oxygen consumption, and energy production, and they control cell death programs such as apoptosis ([@bib7], [@bib21]). Moreover, mitochondria play key roles in cancer stem cells (CSCs), which are believed to confer histopathological heterogeneity and drug and/or radiation resistance in cancer tissues. The structure and dynamics of mitochondria are related to CSC-related traits such as self-renewal capacity and tumorigenic potential ([@bib13], [@bib33]), and the translation of mitochondrial (mt) DNA-encoded genes can be a potential target for anticancer drugs ([@bib26]). However, our knowledge regarding the molecular mechanism underlying the mitochondrial control of CSC fate is limited.

Nucleoside modifications have two roles in cancer biology: as an input for cellular decisions and as an output from nucleotide metabolism. The former is known to control cell growth and differentiation through epigenetic regulation ([@bib3], [@bib16], [@bib34]), whereas the latter is known as a by-product of nucleotide metabolism. However, previous studies have shown that modified nucleosides can regulate the fate of cancer cells. When artificially applied, N6-isopentenyladenosine (i^6^A), a modified nucleoside derived from tRNAs, induces cell-cycle arrest and cell death in many types of cancer cells, including glioblastoma cells ([@bib4], [@bib6], [@bib17], [@bib22], [@bib23]). Nevertheless, whether endogenous i^6^A exerts the same effect and inhibits tumor growth remains unknown. Endogenous i^6^A may also attenuate antitumor effects on cancer cells.

i^6^A modifications exist only on the adenosine at position 37, which is a nucleotide neighboring the anticodon region in tRNAs ([@bib31]). TRIT1 is an isopentenyl transferase that converts A into i^6^A in mammals ([@bib24]). Moreover, i^6^A is converted to 2-methylthio (ms^2^) i^6^A (ms^2^i^6^A) by cyclin-dependent kinase 5 regulatory subunit associated-protein 1 (CDK5RAP1) in the mitochondria of mammalian cells ([@bib31]). CDK5RAP1, a mitochondria-localizing methylthio-modifying enzyme, is essential for the conversion of i^6^A to ms^2^i^6^A in mt-RNAs that read codons for Trp, Tyr, Phe, and Ser ([@bib31]). This enzyme contributes to the maintenance of cellular respiration and metabolism in skeletal and cardiac muscles via the precise translation of mt-DNA-encoded genes. Therefore, CDK5RAP1 deficiency reduces OXPHOS-related protein levels and triggers myopathy in mice and humans ([@bib31]). Because intramitochondrial translation is a key element for sustaining malignancy and CSC-related properties, we hypothesized that CDK5RAP1 contributes to intramitochondrial translation and is essential for malignancy.

Although the importance of mitochondrial translation in malignant tumors has been emphasized, the role of CDK5RAP1 in this process is not fully understood. A previous study suggested that CDK5RAP1 deficiency induces cell-cycle arrest and apoptosis in breast cancer via the ROS/JNK signaling pathway ([@bib30]). In the present study, however, we demonstrated that CDK5RAP1 deficiency induced excessive autophagy but not apoptosis and was sufficient to repress glioma-initiating cell (GIC)-related capacities. Mechanistically, CDK5RAP1 deficiency caused an intracellular accumulation of i^6^A, which needs to be converted to ms^2^i^6^A to avoid the tumor-suppressive effects of i^6^A. The results of the present study revealed a novel role of mitochondria in cancer biology, that is, a modification of mitochondrial tRNAs functions as an antidotal machinery to sustain the GIC-related traits.

Results {#sec2}
=======

CDK5RAP1 Is Required to Sustain GIC-Related Traits {#sec2.1}
--------------------------------------------------

Because GICs have been proposed to contribute to the malignant properties of glioma tissues ([@bib19]), we first examined whether CDK5RAP1 controlled the stemness of patient-derived GICs. In glioma biology, GIC-related traits are usually defined by self-renewal capacity measured using sphere formation assay, the expression of stem cell markers, and tumor-propagating potential assessed by xenograft tumor models ([@bib28]). We prepared three types of GIC cell lines categorized by their molecular subtype: JKGIC1 (mesenchymal), JKGIC2 (proneural), and JKGIC5 (proneural) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Upon CDK5RAP1 knockdown by infection with lentiviruses containing shCDK5RAP1, the sphere-forming capacity of these GICs was significantly reduced ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). Single cell-sphere formation assay showed that CDK5RAP1 was required for the *in vitro* self-renewal capacity of JKGIC2 and JKGIC5 ([Figure 1](#fig1){ref-type="fig"}B). CDK5RAP1 deficiency suppressed the protein and mRNA levels of the transcriptional factors essential for GIC (e.g., Sox2, Oig2, POU3F2, and SALL2, [@bib28]) and GIC-related markers ([Figures 1](#fig1){ref-type="fig"}C, [S1](#mmc1){ref-type="supplementary-material"}D, S1F, and S1G). Immunofluorescence analyses revealed that CDK5RAP1 was required to sustain the undifferentiated state of GICs, as indicated by the loss of Sox2, Nestin, and CD133 expression in shCDK5RAP1-infected cells ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}E).Figure 1CDK5RAP1 Is Required to Sustain GIC-Related Traits(A) *Left*: Quantification of primary and secondary spheres formed by JKGIC2-shControl, JKGIC2-shCDK5RAP1\#1, JKGIC2-shCDK5RAP1\#2 and JKGIC5-shControl, JKGIC5-shCDK5RAP1\#1, JKGIC5-shCDK5RAP1\#2 cells. CDK5RAP1 is required to sustain the anchorage-independent growth capacity of GICs. The data are presented as the number of spheres formed from 2,000 seeded cells. Each bar represents the SD value of four independent replicates. \*p \< 0.05. Sequence information of shRNAs is show in [Table S1](#mmc1){ref-type="supplementary-material"}. *Right*: Representative phase contrast images of these cells. Scale bars, 100 μm.(B) Quantification of primary spheres initiated from the single cells of JKGIC2-shControl, JKGIC2-shCDK5RAP1\#1, JKGIC2-shCDK5RAP1\#2, JKGIC2-shCDK5RAP1\#5 and JKGIC5-shControl, JKGIC5-shCDK5RAP1\#1, JKGIC5-shCDK5RAP1\#2, JKGIC5-shCDK5RAP1\#5. CDK5RAP1 is required for sustaining the sphere formation capacity of GICs. The data are presented as the percentage of spheres formed from 48 wells of single cells. Each bar represents the SD value of four independent replicates. \*p \< 0.05.(C) *Left*: Representative immunoblotting images of GIC markers in shControl- and shCDK5RAP1-transfected JKGIC2 cells. Sox2, Olig2, POU3F2, and SALL2 levels were determined 4 days after infection with respective shRNA-encoding lentivirus. GAPDH served as a loading control. The experiment was repeated three times. The information of antibodies used in the present study is shown in [Table S2](#mmc1){ref-type="supplementary-material"}. *Right*: Relative expression levels of *CDK5RAP1* 4 days after the lentiviral transduction of shRNAs. Each bar represents the SD value from three independent replicates. Sequence information of the primers for qPCR is shown in [Table S1](#mmc1){ref-type="supplementary-material"}.(D) Representative immunostaining images of JKGIC2-shControl and JKGIC2-shCDK5RAP1 cells. Transfection with shCDK5RAP1 reduced the number of Sox2-and Nestin-positive cells. Scale bars, 20 μm.(E--G) CDK5RAP1 is required to sustain the tumorigenic potential of GICs. After shRNA induction, JKGIC1, JKGIC2, and JKGIC5 cells were subcutaneously injected (E, n = 3 per condition) and JKGIC2 were intracranially (F, n = 5 per condition) injected. Notably, *CDK5RAP1* knockdown prolonged the overall survival of the mice with brain tumors (G). \*p \< 0.05. Scale bars: 1 cm in (E) and 2 mm in (F).Also see [Figure S1](#mmc1){ref-type="supplementary-material"}.

We then asked whether CDK5RAP1 was required to sustain tumor-propagating capacity in subcutaneous xenograft model in immunocompromised mice (BALB/c-nu). As shown in [Figure 1](#fig1){ref-type="fig"}E, CDK5RAP1 deficit significantly reduced tumor size in all types of xenograft models. For the orthotopic glioma model, we injected JKGIC2-shControl (JKGIC2 cells infected with lentiviruses containing pLKO.1-shControl) or JKGIC2-shCDK5RAP1 (pLKO.1-shCDK5RAP1\#2) cells into the left cerebral hemisphere of ICR-nu mice. The loss of CDK5RAP1 attenuated tumor growth of JKGIC2 ([Figure 1](#fig1){ref-type="fig"}F) and prolonged the overall survival of mice with brain tumors ([Figure 1](#fig1){ref-type="fig"}G). These data clearly show that CDK5RAP1 is crucial for sustaining GIC-related characteristics.

CDK5RAP1 Controls GIC Properties Independently of Mitochondrial Translation, Dynamics, and Functions {#sec2.2}
----------------------------------------------------------------------------------------------------

Because mitochondrial function is essential for the maintenance of GIC properties ([@bib25]) and because CDK5RAP1 is required for the efficient translation of mitochondrial proteins encoded by mitochondrial DNA ([@bib31]), we hypothesized that the loss of GIC-related traits upon CDK5RAP1 knockdown was caused by mitochondrial dysfunction, probably by a deficiency in intramitochondrial translation ([Figure 2](#fig2){ref-type="fig"}A). To test this hypothesis, we analyzed the effect of CDK5RAP1 knockdown on mitochondrial function as measured by the oxygen consumption rate (OCR) in GICs. In GICs, differentiation cues (e.g., 10% FBS) induce a regulatory switch in mitochondrial functions ([Figure S2](#mmc1){ref-type="supplementary-material"}A). For this assay, we prepared three types of JKGIC2 cells: JKGIC2-shControl, JKGIC2-shCDK5RAP1\#2, and JKGIC2-shCDK5RAP1\#5 (the knockdown efficiency of each shRNA is shown in [Figure 2](#fig2){ref-type="fig"}B). Surprisingly, CDK5RAP1 knockdown did not affect the OCR, indicating that CDK5RAP1 is not essential for mitochondrial respiration in GICs ([Figure 2](#fig2){ref-type="fig"}B). This was specific to GICs because we observed a significant change in the OCR in shCDK5RAP1-infected U87MG cells, a non-GIC line ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Moreover, CDK5RAP1 deficiency did not alter mitochondrial shape or dynamics, which are considered crucial for controlling GIC-related traits ([@bib33]) ([Figure 2](#fig2){ref-type="fig"}C). Electron microscopy analysis showed that there was no significant difference in the mitochondrial shape or length between control and CDK5RAP1-deficient GICs ([Figure 2](#fig2){ref-type="fig"}D).Figure 2CDK5RAP1 Deficiency Has No Effect on Mitochondrial Translation, Dynamics, or Function(A) An initial hypothesis suggesting that the loss of GIC-related traits by CDK5RAP1 deficiency is caused by the failure of intramitochondrial translation.(B) *Left*: Representative oxygen consumption rates in shControl- and shCDK5RAP1-transfected JKGIC2 cells. Respiratory coupling was not affected by CDK5RAP1 knockdown. n = 5 per condition. *Right*: Relative expression levels of *CDK5RAP1* 4 days after the lentiviral transduction of shRNAs. Each bar represents the SD value from three independent replicates.(C) MitoTracker staining shows that mitochondrial shape was not altered upon *CDK5RAP1* knockdown in JKGIC2.(D) *Left*: Representative electron microscopy images of mitochondrial structures. Scale bars, 500 nm. *Right*: Mitochondrial length was not altered upon *CDK5RAP1* knockdown. n = 38 for shControl and n = 87 for shCDK5RAP1\#2.(E) The level of MTCO1 encoded by mitochondrial DNA was determined 4 days after shRNA lentiviral infection. GAPDH served as a loading control. The same results were reproduced three times.(F) Quantification of primary spheres formed from 2,000 JKGIC1 cells, which were transfected with shRNAs against CDK5RAP1, TUFM, or TSFM. Only shRNAs against CDK5RAP1 reduced the number of spheres formed. Each bar represents the SD value from four independent replicates. \*p \< 0.05.Also see [Figure S2](#mmc1){ref-type="supplementary-material"}.

We then investigated whether CDK5RAP1 deficiency induced translation failure in mitochondrial proteins in GICs. As a positive control, we transduced shRNAs against the mitochondrial translation elongation factors TUFM or TSFM, which are crucial for the translation of mitochondrial proteins encoded by mitochondrial DNA ([@bib2], [@bib5]). In JKGIC1 cells, knockdown of TUFM or TSFM but not of CDK5RAP1 resulted in the profound loss of mitochondrially encoded cytochrome *c* oxidase I (MTCO1) ([Figure 2](#fig2){ref-type="fig"}E). Importantly, TUFM or TSFM knockdown had no effect on the sphere-forming capacity of GICs, whereas CDK5RAP1 knockdown significantly reduced the number of spheres formed ([Figure 2](#fig2){ref-type="fig"}F). We also confirmed these phenomena in JKGIC2 cells ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Interestingly, we noticed that CDK5RAP1 deficit reduced the level of NDUFB8 (a component of mitochondrial complex I encoded by nuclear gene) and thus induced the loss of complex I activity but did not attenuate the levels of mitochondrial proteins encoded by mitochondrial genome such as ND6, cytochrome *b*, and MTCO1 ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). These data clearly show that intramitochondrial translation is not fundamental for sustaining GIC-related properties in glioblastoma cells and indicate that CDK5RAP1 deficiency affects the properties of GICs in an intramitochondrial translation-independent manner.

CDK5RAP1 Knockdown Induces Excessive Autophagy, which Critically Determines GIC Fate {#sec2.3}
------------------------------------------------------------------------------------

A previous study showed that CDK5RAP1 knockdown induced cell-cycle arrest and apoptosis in breast cancer cell lines via the activation of the JNK signaling pathway ([@bib30]). Therefore, we examined whether CDK5RAP1 knockdown induced apoptosis in GICs. However, CDK5RAP1 knockdown did not induce the activation of caspase 3 in JKGIC1, JKGIC2, and JKGIC5 cells ([Figure 3](#fig3){ref-type="fig"}A) and did not increase the number of TUNEL-positive cells in JKGIC2 cell lines ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Instead, we found that CDK5RAP1 knockdown induced autophagy as indicated by an increased presence of autophagosomes and autolysosomes in electron microscopy experiments ([Figure 3](#fig3){ref-type="fig"}B). We further validated the induction of the autophagic response in GICs upon CDK5RAP1 knockdown by immunofluorescence analysis of LC3 puncta formation and by immunoblotting analysis of LC3-II induction, AMPK activation, and mTOR inhibition ([Figures 3](#fig3){ref-type="fig"}C, 3D, [S3](#mmc1){ref-type="supplementary-material"}B, and S3C).Figure 3CDK5RAP1 Knockdown Induces Excessive Autophagy, Which Critically Determines GIC Fate(A) CDK5RAP1 knockdown did not activate caspase-3 in JKGIC1, JKGIC2, and JKGIC5 cells. CDDP-treated cells served as a positive control of apoptotic status.(B) *Left*: Representative electron microscopy images of the autophagic response. JKGIC2 cells were fixed after 4 days of lentiviral transduction of each shRNAs. *Right*: CDK5RAP1 knockdown increased the number of autophagosomes and autolysosomes. n = 5 per condition. \*p = 0.0391 versus shControl. Scale bars, 1 μm.(C) Representative immunostaining images for LC3 in JKGIC2 cells. CDK5RAP1 knockdown induces LC3 puncta formation. Rapamycin-treated cells served as a positive control of LC3 puncta formation. Scale bars, 10 μm.(D) Immunoblotting analyses of mTOR, AMPK, and LC3 show that CDK5RAP1 knockdown activates the autophagic program in JKGIC2 cells.(E) *Left*: mTOR inhibition with rapamycin triggers the autophagic response and decreases Nestin expression in JKGIC2 cells. n = 5 per condition. *Right*: Dose-dependent effect of rapamycin on the number of spheres formed from 2,000 JKGIC2 cells. Each bar represents the SD value from four independent replicates. \*p \< 0.05.(F) Comparison of sphere formation by JKGIC2 and JKGIC5 cells transfected with shRNAs against CDK5RAP1 in the presence or absence of shRNAs against ATG5. ATG5 knockdown reduces the sphere-forming capacity but successfully rescues the shCDK5RAP1-mediated decrease in the anchorage-independent growth of GICs. Each bar represents the SD value from four independent replicates. \*p \< 0.05.Also see [Figure S3](#mmc1){ref-type="supplementary-material"}.

Previous studies have demonstrated that mTOR inhibition suppresses the stemness of GICs ([@bib12], [@bib27]). Indeed, rapamycin treatment attenuated the cellular growth and promoted the autophagic program in GICs ([Figures 3](#fig3){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}D). We then investigated whether the autophagic response triggered by CDK5RAP1 knockdown could be rescued by knocking down Atg5, which is essential for the autophagy pathway. Although Atg5 knockdown slightly reduced the number of spheres formed by JKGIC2 and JKGIC5 cells, it successfully rescued the loss of anchorage-independent growth driven by CDK5RAP1 knockdown ([Figures 3](#fig3){ref-type="fig"}F and [S3](#mmc1){ref-type="supplementary-material"}E). Excessive autophagy results in the growth inhibition of GICs ([@bib29]). In agreement with our previous study, CDK5RAP1 knockdown significantly inhibited the growth of JKGIC1 and JKGIC2 cells ([Figure S3](#mmc1){ref-type="supplementary-material"}F). These data demonstrate that GICs require CDK5RAP1 to avoid excessive autophagy, which critically represses the GICs\' cell growth.

Treatment with N6-Isopentenyladenosine (i^6^A) Induces Excessive Autophagy and Loss of GIC-Related Traits {#sec2.4}
---------------------------------------------------------------------------------------------------------

Thus far, the present study has revealed that CDK5RAP1 maintains GIC-related traits by inhibiting excessive autophagy but not by controlling intramitochondrial translation. How does CDK5RAP1 maintain the characteristics by inhibiting excessive autophagy? CDK5RAP1 is a mitochondrial enzyme that modifies nucleosides by adding methylthio groups and is crucial for the conversion of i^6^A to ms^2^i^6^A at A37 of mt-tRNAs ([@bib31]). Consistent with this, the intracellular distribution of ms^2^i^6^A-containing tRNAs was limited to the mitochondria of GICs, as confirmed by immunofluorescence analysis with an anti-ms^2^i^6^A antibody, which specifically recognizes ms^2^i^6^A-containing tRNAs ([Figure 4](#fig4){ref-type="fig"}A). This result led us to hypothesize that CDK5RAP1 enhances the conversion of i^6^A to ms^2^i^6^A in mt-tRNAs of GICs, resulting in the inhibition of excessive autophagy.Figure 4Treatment with N6-isopentenyladenosine (i^6^A) Induces Excessive Autophagy and Loss of GIC-Related Traits(A) Representative images of immunostaining with an anti-ms^2^i^6^A antibody and MitoTracker in JKGIC2 cells. Note that the intracellular distribution of ms^2^i^6^A is limited to the mitochondria. Scale bars, 20 μm.(B) Treatment with i^6^A, but not ms^2^i^6^A, for 24 h induces increases in LC3-II levels in JKGIC2 cells. GAPDH served as a loading control. The same results were reproduced three times.(C) Treatment with i^6^A, but not ms^2^i^6^A, activates the autophagic program in JKGIC2 cells.(D) Treatment with i^6^A for 24 h induces LC3 puncta formation in JKGIC2 cells.(E) Quantification of primary spheres formed by JKGIC2 cells treated with i^6^A or ms^2^i^6^A. Treatment with i^6^A reduces the number of spheres, but this reduction is not rescued by the further addition of ms^2^i^6^A. Each bar represents the SD value from four independent replicates. \*p \< 0.05.(F and G) Immunoblotting (F) and immunostaining (G) indicate that treatment with i^6^A, but not ms^2^i^6^A, decreases the protein levels of Nestin and Sox2 in JKGIC2 cells.(H) Quantification of primary spheres formed by JKGIC2 cells (2,000/well) transfected with shRNAs against ATG5 and i^6^A. ATG5 knockdown successfully rescues the i^6^A-induced loss of stemness in JKGIC2 cells. Each bar represents the SD value from four independent replicates. \*: p \< 0.05.(I and J) Exogenous transduction of murine Cdk5rap1 increases the amount of Nestin protein (I) and the number of spheres formed by JKGIC2 cells (2,000/well) (J). Each bar represents the SD value from four independent replicates. \*p \< 0.05.(K) Ectopic expression of murine Cdk5rap1 prevents the loss of anchorage-independent growth ability in JKGIC2 due to exogenous treatment with 4 and 8 μM i^6^A. The data are presented as the number of spheres formed from 2,000 cells. Each bar represents the SD value from four independent replicates. \*p \< 0.05.Also see [Figure S4](#mmc1){ref-type="supplementary-material"}.

Because previous studies have shown that treatment with exogenous i^6^A induces tumor-suppressive effects such as apoptotic or autophagic cell death in cancer cells ([@bib4], [@bib6], [@bib17], [@bib22], [@bib23]), we examined whether i^6^A treatment induced excessive autophagy and consequent loss of GIC-related traits. In JKGIC2 cells, i^6^A treatment increased the intracellular concentration of i^6^A in a dose-dependent manner, and the intracellular concentration of i^6^A in the cells treated with 4 μM i^6^A reached the same level as that in JKGIC2 cells transfected with shCDK5RAP1 ([Figure S4](#mmc1){ref-type="supplementary-material"}A). However, exogenous i^6^A did not induce a consequent increase in ms^2^i^6^A ([Figure S4](#mmc1){ref-type="supplementary-material"}A), suggesting that CDK5RAP1 could not convert free i^6^A to ms^2^i^6^A. i^6^A treatment activated the autophagic program, as shown by LC3-II induction, AMPK activation, mTOR signaling pathway inhibition in JKGIC2 and JKGIC5 cells ([Figures 4](#fig4){ref-type="fig"}B, 4C, and [S4](#mmc1){ref-type="supplementary-material"}B), and LC3 puncta formation in JKGIC2 cells ([Figure 4](#fig4){ref-type="fig"}D). i^6^A also attenuated the anchorage-independent cell growth and reduced the expression of GIC markers such as Sox2 and Nestin ([Figures 4](#fig4){ref-type="fig"}E--4G, [S4](#mmc1){ref-type="supplementary-material"}B, and S4C). To validate that the loss of GIC-related traits driven by i^6^A treatment was in the context of autophagy, we prepared shControl- and shATG5-transfected JKGIC2 cells and treated them with variable concentrations of i^6^A. As expected, ATG5 knockdown successfully mitigated the phenotypic outcome of i^6^A ([Figure 4](#fig4){ref-type="fig"}H). In contrast, ms^2^i^6^A treatment induced neither autophagy nor loss of GIC-related traits and did not prevent the phenotypic outcomes triggered by i^6^A treatment ([Figures 4](#fig4){ref-type="fig"}B--4G). Moreover, N6-isopentenyladenine (i^6^Adenine) did not repress the anchorage-independent growth of JKGIC2 cells ([Figure S4](#mmc1){ref-type="supplementary-material"}D). These data suggest that isopentenyl modification only on adenosine molecules elicits tumor-suppressive effects and that this increase in isopentenyl groups can be ameliorated via detoxification by CDK5RAP1-mediated methylthiolation ([Figure S4](#mmc1){ref-type="supplementary-material"}E).

We next investigated whether the elevated expression levels of CDK5RAP1 conferred an antiautophagic phenotype to GICs. For this purpose, we transduced control red fluorescent protein (RFP) (pTomo-RFP) or murine Cdk5rap1 (pTomo-mCdk5rap1) into JKGIC2 cells ([Figure 4](#fig4){ref-type="fig"}I). Cdk5rap1 promoted the growth capacity of JKGIC2 and elevated the expression levels of the undifferentiated marker Nestin ([Figures 4](#fig4){ref-type="fig"}I and 4J). Exogenous Cdk5rap1 significantly attenuated the inhibitory effect of 3--4 μM i^6^A on the anchorage-independent growth ability and cell viability of JKGIC2 cells ([Figures 4](#fig4){ref-type="fig"}K and [S4](#mmc1){ref-type="supplementary-material"}F). However, overexpression of Cdk5rap1 failed to attenuate the inhibitory effect of higher concentrations (\>6 μM) of exogenous i^6^A ([Figures 4](#fig4){ref-type="fig"}K and [S4](#mmc1){ref-type="supplementary-material"}F). Taken together, these results suggest that treatment with exogenous i^6^A induces excessive autophagy and loss of GIC-related traits. Cdk5rap1 overexpression induces the conversion of endogenous i^6^A to ms^2^i^6^A on tRNA species, resulting in a decrease in total i^6^A (endogenous + exogenous i^6^A) levels in GICs and consequent attenuation of the inhibitory effect of i^6^A on the anchorage-independent growth ability and cell viability of GICs when treated with 3--4 μM i^6^A. In contrast, when cells are treated with a high concentration (\>6 μM) of i^6^A, the intracellular i^6^A level may reach the concentration corresponding to an antitumor effect. Therefore, the overexpression of Cdk5rap1 fails to attenuate the inhibitory effect of excessive exogenous i^6^A.

CDK5RAP1 Balances i^6^A and ms^2^i^6^A Concentrations in GICs in Response to the Microenvironment {#sec2.5}
-------------------------------------------------------------------------------------------------

To demonstrate whether CDK5RAP1 regulates endogenous concentrations of i^6^A and ms^2^i^6^A in GICs, we analyzed \[i^6^A\] and \[ms^2^i^6^A\] in mock-, shCDK5RAP1-, and mCdk5rap1-transduced JKGIC1, or JKGIC2 cells by mass spectrometry. The results showed that the ratio of total \[i^6^A\]/\[i^6^A + ms^2^i^6^A\] was increased in shCDK5RAP1-transfected cells but decreased in murine Cdk5rap1-overexpressing cells ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A).Figure 5CDK5RAP1 Balances i^6^A and ms^2^i^6^A Concentrations in GICs in Response to the Microenvironment(A) Mass spectrometry analysis of \[i^6^A\] and \[ms^2^i^6^A\] from the lysates of shControl- and shCDK5RAP1-, RFP-, mCdk5rap1-transfected JKGIC2 cells. Note that CDK5RAP1 knockdown induces an increase in the relative \[i^6^A\] in GICs, whereas CDK5RAP1 overexpression reduces the relative \[i^6^A\]. Each bar represents the SD value from three independent replicates. \*p \< 0.05.(B) Schematic representation of the molecular characteristics of CDK5RAP1. Cysteine residues in the UPF0004 and radical SAM domains are crucial for the stabilization of the \[4Fe-4S\] clusters. The mitochondria localization signal (MLS) allows CDK5RAP1 to localize to the mitochondria. The TRAM domain is predicted to interact with tRNA species.(C) The M.I. of ms^2^i^6^A corresponding to each mt-tRNA and tRNA expression level in JKGIC2 cells cultured in the presence of 21% and 1% O~2~. The M.I.s in all CDK5RAP1-targeted tRNA species are increased under hypoxic conditions, but tRNA expression is not. The data are presented as the M.I. relative to the cells cultured under normoxia. Each bar represents the SD value from two independent replicates. For the procedure regarding the measurement of M.I., also see [Figure S5](#mmc1){ref-type="supplementary-material"}D.(D) Hypoxic conditions decrease intracellular \[i^6^A\] and increase the secretion of ms^2^i^6^A by JKGIC2 cells. The data are presented as the percentage of the levels under normoxia. Each bar represents the SD value from three independent replicates. \*p \< 0.05.(E and F) Hypoxic conditions significantly increased the expression levels of *VEGF* mRNA (E) but not *CDK5RAP1* mRNA (F) in JKGIC2 cells. Each bar represents the SD value from four independent replicates. \*p \< 0.05.Also see [Figure S5](#mmc1){ref-type="supplementary-material"}.

Because the biochemical reaction of CDK5RAP1-mediated 2-methylthio conversion of i^6^A is strictly regulated within the mitochondria and is detected solely in mt-tRNAs ([@bib9]) and because ms^2^i^6^A is predominantly enriched in cell culture medium (∼9.6 times more than the concentration inside cells, [Figure S5](#mmc1){ref-type="supplementary-material"}B), these data suggest that CDK5RAP1 decreases \[i^6^A\] by promoting the 2-methylthio conversion of i^6^A in the mitochondria and that the consequent ms^2^i^6^A derived from degraded mt-tRNAs is excreted ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

Two conserved domains in CDK5RAP1, namely, UPF0004 and the radical SAM domain, are essential for CDK5RAP1 activity ([@bib9]). The cysteine residues in these domains are required for the interaction with both \[4Fe-4S\] clusters, which provide the sulfur atoms for interactions with i^6^A molecules ([Figure 5](#fig5){ref-type="fig"}B). Given that \[4Fe-4S\] clusters are stable under anoxic conditions ([@bib8]), we speculated that CDK5RAP1 was activated under hypoxic conditions. To test this possibility, we performed quantitative PCR measurements of tRNA 2-methylthio modifications. We extracted total RNA from GICs cultured in the presence of either 21% or 1% O~2~. The ms^2^i^6^A modifications in each mt-tRNA are represented as a modification index (M.I.) as reported previously ([Figure S5](#mmc1){ref-type="supplementary-material"}D) ([@bib32]). As expected, hypoxic culture conditions significantly increased the M.I. of each CDK5RAP1-targeted mt-tRNA, whereas hypoxic conditions had no effect on the expression of the tRNAs ([Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}E). Consistent with this outcome, as observed in mCdk5rap1-overexpressing JKGIC1 and JKGIC2 cells, the ratio of total \[i^6^A\]/\[i^6^A + ms^2^i^6^A\] under hypoxic conditions was decreased, whereas the ratio of \[ms^2^i^6^A\]/\[i^6^A + ms^2^i^6^A\] was increased ([Figures 5](#fig5){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}F). Hypoxia-inducible factor 1α (HIF-1α) is the inducible subunit of the HIF-1 transcription factor that regulates the expression of genes involved in the response to hypoxia. Vascular endothelial growth factor (VEGF) is one of the genes upregulated by HIF-1 ([@bib20]). *VEGF* expression was significantly increased in GICs cells cultured under 1% O~2~ ([Figures 5](#fig5){ref-type="fig"}E, [S5](#mmc1){ref-type="supplementary-material"}G, and S5I). In contrast, there was no difference in the expression level of *CDK5RAP1* in cells cultured in the presence of 21% to 1% O~2~ ([Figures 5](#fig5){ref-type="fig"}F, [S5](#mmc1){ref-type="supplementary-material"}H, and S5J). To further validate that \[4Fe-4S\] clusters are required for this reaction, we treated cells with deferoxamine (100 μM) to chelate intracellular Fe ions and measured the M.I. of the mt-tRNAs, and we found that Fe chelation reduced the M.I ([Figure S5](#mmc1){ref-type="supplementary-material"}K). These data indicate that CDK5RAP1 activity is controlled by the microenvironment, such as hypoxic conditions and the concentration of intracellular Fe ions.

CDK5RAP1 Activity Is Upregulated in the Hypoxic Region of Human Glioblastoma and Is Required to Sustain the Sphere-forming Capacity of Malignant Cells but Not Normal Brain Cells {#sec2.6}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To gain insights into the contribution of CDK5RAP1 to human glioblastoma multiforme (GBM) pathophysiology, we harvested several specimens, including the "tumor core" and "peritumor normal area," from three patients with GBM and analyzed the concentrations of i^6^A and ms^2^i^6^A by mass spectrometry. Intriguingly, \[i^6^A\] was significantly increased in the tumor core compared with that in the peritumor normal area in all cases ([Figure 6](#fig6){ref-type="fig"}A). Following the logic established by these observations and the above-mentioned data, we hypothesized that glioblastoma cells require CDK5RAP1 activity to detoxify i^6^A to protect cells from excessive autophagy. However, the expression level of CDK5RAP1 in the tumor core was the same as that in the peritumor normal area ([Figure 6](#fig6){ref-type="fig"}B). Because the GBM core is known to be hypoxic ([@bib11]), we speculated that CDK5RAP1 activity was upregulated in the tumor core of GBM specimens. RT-PCR analysis of a HIF target gene, *VEGF,* indicated that the tumor core was more hypoxic than the peritumor normal area ([Figure 6](#fig6){ref-type="fig"}C). As expected, mass spectrometry analysis showed that \[ms^2^i^6^A\] in the tumor core was higher than that in the peritumor normal area ([Figure 6](#fig6){ref-type="fig"}D). Immunofluorescence analysis revealed that Nestin-positive tumor cells overlapped with ms^2^i^6^A-positive tumor cells in the tumor core area, whereas ms^2^i^6^A-negative tumor cells did not overlap with Nestin-positive cells ([Figure 6](#fig6){ref-type="fig"}E), suggesting that CDK5RAP1, upon activation under hypoxic conditions, promotes the maintenance of GIC-related traits.Figure 6CDK5RAP1 Is Essential for Sustaining the GIC-Related Traits of GICs but Not That of Normal Brain Cells(A) *Left*: Representative MR image and H&E staining of the brain tissue in a patient (case 1) with GBM. Tumor core and peritumor samples were harvested to extract RNA and nucleosides. *Right*: Mass spectrometry analysis of relative \[i^6^A\] shows that \[i^6^A\] is increased in the tumor core. Each bar represents the SD value from three independent replicates. \*p \< 0.05 versus the peritumor sample.(B) Expression levels of *CDK5RAP1* in human GBM specimens from the tumor core and peritumor areas are not significantly different. n = 5 per sample type.(C) Expression level of *VEGF* in the peritumor and tumor core areas of patients with GBM. n = 5 per sample type.(D) Mass spectrometry analysis of relative \[ms^2^i^6^A\] in the peritumor and tumor core areas of specimens from patients with GBM. Each bar represents the SD value from three independent replicates. \*p \< 0.05 versus the peritumor sample.(E) Representative images of immunofluorescence analysis with anti-ms^2^i^6^A and anti-Nestin antibodies in the tumor core of patients with GBM. Note that the ms^2^i^6^A-positive cells and Nestin-positive cells overlap.(F) Untreated NSCs, NSCs transformed with oncogenic lentiviruses, and mouse primary neurons transformed with oncogenic lentiviruses (all from *Cdk5rap1*^*fl/fl*^ mouse brains) either with or without transduced adenoviruses harboring Cre recombinase were subjected to the sphere formation assay. Transformed cells but not NSCs require Cdk5rap1 to sustain their anchorage-independent growth capacity. The data are presented as the number of spheres formed from 2,000 cells. Each bar represents the SD value from four independent replicates. \*p \< 0.05.(G) Representative data of the gliosphere initiation assay. Primary astrocytes from *wild-type* or *Cdk5rap1*^*fl/fl*^ mouse brains were infected with Cre-inducible HRas^G12V^-expressing pTomo lentiviruses. The cells were further infected with adenoviruses harboring Cre recombinase to activate HRas^G12V^ and recombine out the *Cdk5rap1* alleles and were cultured in GIC medium for 7--10 days. The numbers of initiated spheres from 50,000 cells were counted. n = 4 per condition. For the procedure of the gliosphere initiation assay, see [Figure S6](#mmc1){ref-type="supplementary-material"}. Cdk5rap1 is required to initiate the formation of gliospheres from primary astrocytes.(H) Quantification of secondary, tertiary, and quaternary spheres formed by the transformed astrocytes harvested from the gliosphere initiation assay described in (G). Cdk5rap1 is required to sustain the self-renewal capacity of the transformed cells. The data are presented as the number of spheres formed from 2,000 cells. Each bar represents the SD value from four independent replicates. \*p \< 0.05.Also see [Figure S6](#mmc1){ref-type="supplementary-material"}.

To demonstrate whether CDK5RAP1 activity was required for the traits of only GICs but not normal neural stem cells (NSCs), we prepared NSCs and primary neurons from *Cdk5rap1*^*fl/fl*^ mouse pups and infected these cells with control pTomo lentivirus or pTomo-shNF1-shp53 lentivirus. Dual knockdown of *NF1* and *p53* allowed the neural cells to acquire GIC-related properties within 1--2 weeks as previously reported ([@bib10]). After several passages, we further infected the cells with adenoviruses harboring Cre recombinase to knockout the *Cdk5rap1* alleles from these cells, after which the cells were subjected to the sphere formation assay. The *Cdk5rap1* knockout resulted in a significant reduction of the anchorage-independent growth in the transformed NSCs and neurons, but not in normal NSCs ([Figure 6](#fig6){ref-type="fig"}F). We further investigated whether Cdk5rap1 was required for the acquisition of GIC-related traits (i.e., gliomagenesis). We transduced Cre-inducible HRas^G12V^/shp53 into astrocytes from wild-type and *Cdk5rap1*^*fl/fl*^ mouse pups. The infected cells were subjected to sphere formation assays upon adeno-Cre infection, which further recombined out the loxP-RFP-loxP cassette to induce HRas^G12V^ expression ([Figure S6](#mmc1){ref-type="supplementary-material"}). In the astrocytes from *Cdk5rap1*^fl/fl^ mice, adeno-Cre infection recombined the *Cdk5rap1* alleles out. Using the gliosphere initiation assay, we found that wild-type astrocytes with *HRas* induction and *p53* knockdown (HRas/shp53) formed numerous spheres, suggesting that the primary astrocytes acquired GIC-related properties. In contrast, the number of spheres in primary astrocytes from *Cdk5rap1*^fl/fl^ mice was lower than that in HRas/shp53 astrocytes, suggesting that astrocytes required Cdk5rap1 to achieve gliomagenesis ([Figure 6](#fig6){ref-type="fig"}G). We then harvested and trypsinized the formed spheres and conducted the sphere formation assay. Similar to the transformed neurons, the anchorage-independent growth of the cells was reduced upon *Cdk5rap1* deletion ([Figure 6](#fig6){ref-type="fig"}H). These data clearly demonstrate that CDK5RAP1 is essential for acquiring and sustaining the GIC-related traits of malignant and transformed cells but not that of normal NSCs.

Discussion {#sec3}
==========

We previously reported that CDK5RAP1 was responsible for the ms^2^ modification of mammalian mt-tRNAs for the Ser (UCN), Phe, Tyr, and Trp codons ([@bib31]). Under stress condition, deficiencies in ms^2^ modification impaired mitochondrial protein synthesis, OXPHOS activity, and ATP synthesis in normal tissues. Although the canonical role of CDK5RAP1 is to regulate the precise translation of mitochondrial DNA-encoded genes, even in the knockout mice the effect of loss-of-CDK5RAP1 can be observed mainly in complex I but not markedly in the other complexes in steady state ([@bib31]). In the present study, we demonstrate that CDK5RAP1 deficiency induces excessive autophagy and the consequent loss of GIC-related traits. Importantly, we reveal that these phenomena are independent from the regulation of intramitochondrial translation by CDK5RAP1 in GICs, and moreover, we show that the intramitochondrial translation seems not to contribute to sustain the GIC-related traits ([Figures 2](#fig2){ref-type="fig"} and [S2](#mmc1){ref-type="supplementary-material"}). In GICs, CDK5RAP1 deficiency attenuates the antidotal effect of ms^2^i^6^A against i^6^A in the mitochondria, resulting in the promotion of tumor-suppressive effects of i^6^A. The present study suggests a novel function of CDK5RAP1-mediated ms^2^ modification corresponding to the detoxification of i^6^A in the mitochondria; GICs readily exploit this function to survive. We propose mitochondria as the sole antidotal machinery against i^6^A, which causes excessive autophagy and the consequent loss of GIC-related traits. The data presented here add a new layer of the function of chemical modification in mitochondrial tRNAs.

The present study showed that CDK5RAP1 was essential for acquiring and sustaining the GIC-related traits of malignant and transformed cells but not that of normal NSCs by the conversion of i^6^A to ms^2^i^6^A. A recent study showed lower proliferation and differentiation capabilities in NSCs in an adult rodent model of severe motor deprivation and a significant reduction in *Cdk5rap1* expression in NSCs in the model ([@bib1]). Although it is unclear that a reduction in *Cdk5rap1* expression impairs proliferation and differentiation capabilities in NSCs, the canonical function and the regulation of precise translation of the mitochondrial protein may be involved in the proliferation and differentiation of NSCs. Thus, the functions of CDK5RAP1 may differ between NSCs and GICs.

In glioblastoma specimens, i^6^A was enriched in the tumor core area. Consistent with this, the expression levels of TRIT1, a mitochondrial tRNA isopentenyl transferase, were elevated in malignant tissues from the REMBRANDT cohort (REpository for Molecular BRAin Neoplasia DaTa, <http://www.betastasis.com/glioma/rembrandt/>). Such environmental conditions can promote excessive autophagy in GICs and consequently repress GIC-related properties, as demonstrated by the present study. To survive in this microenvironment, GICs require robust CDK5RAP1 activity. However, the expression of *CDK5RAP1* in the tumor core was the same as that in the peritumoral normal area. Therefore, it may be important for GICs to survive under hypoxic conditions, such as those in the tumor core, to activate CDK5RAP1. CDK5RAP1 has two \[4Fe-4S\] clusters, which are essential for its enzymatic activity and are sensitive to oxygen ([@bib31]). As shown in the present study, the activity of CDK5RAP1 was drastically increased under hypoxic conditions, although its expression was not induced under these conditions ([Figures 5](#fig5){ref-type="fig"}C--5F). The hypoxic area is known to harbor a subset of cells, known as CSCs, that have stem cell-like properties due to the induction of stemness genes such as Oct4, c-myc, and Nanog. Moreover, hypoxia induces drug resistance in GICs by activating several pathways mediated by COX-2, the PI3K pathway, AP1, c-Jun, Pim1, or Stat3 ([@bib14]). Our findings suggest a novel importance of the hypoxic environment for the survival and maintenance of GIC-related traits. Thus, GICs likely require continuous activation of CDK5RAP1.

The results of the present study show that CDK5RAP1 deficiency induces excessive autophagy and the consequent loss of stemness in GICs but not in normal neurons or NSCs. The Warburg effect is a metabolic phenomenon characterized by increased glycolytic activity, decreased mitochondrial oxidative phosphorylation, and lactate production and is often observed in GICs ([@bib15]). Functional differences in CDK5RAP1 between normal cells and GICs may be due to the difference in the metabolic phenotypes of the mitochondria in the cells.

A number of studies have shown that exogenous application of i^6^A has a strong antitumor effect *in vitro* ([@bib4], [@bib6], [@bib17], [@bib22], [@bib23]). In agreement with previous studies, the present study showed that i^6^A inhibited the GIC-related traits and induced autophagic cell death and that exogenous i^6^A was not converted to ms^2^i^6^A by CDK5RAP1. These results suggest that i^6^A is a promising therapeutic molecule to target GICs. However, a higher concentration (\>4 μM) of exogenous i^6^A was required for the antitumor effect against GICs. The effective concentration of exogenous i^6^A seems to be much higher than endogenous i^6^A produced from degraded tRNAs. Importantly, the level of intracellular i^6^A when treated with 4 μM i^6^A was consistent with that in shCDK5RAP1-transfected JKGIC2 cells ([Figure S4](#mmc1){ref-type="supplementary-material"}A). These results suggest that the membrane permeability of i^6^A is poor and/or that exogenous i^6^A is rapidly excreted after entering GICs. It may be important for clinical applications to develop delivery systems that can effectively deliver and maintain i^6^A in GICs. Moreover, i^6^A was significantly enriched in the tumor core where GICs are abundant, suggesting that i^6^A alone may be ineffective in combating GICs in the hypoxic tumor core that have constitutively active CDK5RAP1. Despite the antitumor effect of i^6^A *in vitro*, few studies have shown this effect *in vivo*. It may be important to combine i^6^A administration with CDK5RAP1 downregulation by either an iron chelator or shRNAs against CDK5RAP1.

In conclusion, CDK5RAP1-mediated modification of mitochondrial tRNAs is crucial for not only the precise translation of mitochondrial DNA-encoded proteins in normal tissues but also the detoxification of endogenous i^6^A in GICs. GICs readily utilize this mechanism to survive.

Limitations of the Study {#sec3.1}
------------------------

In this study, we were unable to generate CDK5RAP1 knockout GICs because the cells could not grow. Therefore, we used the knockdown cells in all experiments.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1--S6, Tables S1 and S2
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